Tag: Bristol-Myers Squibb

  • Health Care Active Movers: Pfizer Inc. (NYSE:PFE), Novavax, Inc. (NASDAQ:NVAX), Bristol-Myers Squibb Co (NYSE:BMY), Merck & Co (NYSE:MRK)

    Pfizer Inc. (NYSE:PFE) shares have received positive recommendation, just as the company pushes forward with efforts to bring a version of its cholesterol control drug Lipitor over the counter. Investment researchers at Thomson Reuters/Verus have issued a “buy” rating on the stock of PFE. Previously the equity market experts at Thomson Reuters/Verus had a “hold” recommendation on the stock. Following the latest recommendation on the stock of PFE, the consensus view is now a “buy,” following comments from about 23 rating firms. Pfizer Inc. (NYSE:PFE) stock opened at $32.34-$32.74 in last session, and closed at $32.69, while the day range of PFE stock is $32.24-$32.74.The stock showed a positive weekly performance of 2.68%.

    Novavax, Inc. (NASDAQ:NVAX)’s shares jumped 3.02% to $6.49. The company announced that it will host a conference call and webcast to report its fourth quarter and year-end 2013 financial results on Monday, March 10, 2014, at 4:30 p.m. ET. Novavax, Inc. (NASDAQ:NVAX) stock opened at $6.40, in last session and closed at $6.38, by gained 1.27%. The 52 week range was $1.68-$6.95.Company’s market capitalization is $1.33 billion.

    Stock analysts at Leerink Swann raised their target price on shares ofBristol-Myers Squibb (NYSE:BMY) from $58.00 to $62.00 in a report issued on Thursday, American Banking News reports. Leerink Swann’s price objective would indicate a potential upside of 15.31% from the company’s current price. Bristol-Myers Squibb Co (NYSE:BMY) stock gained 5.48% and finished the last session at $56.42. The EPS of the stock remained 1.55.Company’s market capitalization is $93.11 billion.

    Shares of Merck & Co. (NYSE:MRK) were the recipient of unusually large options trading on Tuesday. Stock investors acquired 25,085 call options on the company, Analyst Ratings Net reports. This represents an increase of 131% compared to the typical daily volume of 10,855 call options. Merck & Co., Inc. (NYSE:MRK) stock opened the session at $57.04, and closed the session at $57.06. The 52 week range of the MRK stock remained $42.76-$57.46 and the day range was $56.91-$57.39.